
THE CADHERIN SUPERFAMILY: BIOLOGICAL SIGNIFICANCE
AND NEUROLOGICAL DIVERSITY
Zaharieva I* *Corresponding Author: Dr. Irina Zaharieva, Department of Medical Genetics, Medical University Sofia, 2 Zdrave str, 1431 Sofia, Bulgaria; Tel./Fax: +359-2-952-03-57; E-mail: irinazaharieva@yahoo.co.uk
page: 19
|
DESMOSOMAL CADHERINS
The desmosomal cadherins are also single-pass transmembrane proteins. Like the classical cadherins, they have five EC domains. They are known for their role in forming desmosomes, which, on their part, are sites of cell-cell adhesion found particularly in tissues subject to mechanical strain (e.g., epidermis, myocardium). There are two subfamilies of desmosomal cadherins: the desmocollins (DSC) and the desmogleins (DSG) with distinct cytoplasmatic region, consisting of a cadherin-related region and catenin-binding C domain. The interaction with the cytoplasmatic binding partners is through catenin-binding C domain. Each type in turn can be divided into three subtypes, depending on their expression in the different cells. Desmocollins and a DSG in combination mediate adhesion through their extracellular parts by homophilic or heterophilic interactions between them and the apposed cells. Plakoglobin and DP are two of the cytoplastic partners. Plakcoglobin binds to the C domain of DSGs and DSCs through its armadillo repeats. Plakoglobin in turn interacts with DP which associates with the intermediate filaments. Plakoglobin can transduce signals to the nucleus by interacting with T-cell transcription factors (TCF). Plakophilins (PPs) are other members of armadillo family that can mediate the link between desmosomal cadherins and the cytoskeleton. This complex protein interaction involving desmosomal cadherins, cytoplasmic partners and filament network leads to the formation of a structure, important to the stability of the respective tissues [3].
Desmosomal cadherins are involved in signal transduction. Plakoglobin can transduce signals to the nucleus by interacting with TCF transcription factors, and through the Wnt pathway can regulate the expression of the anti-apoptotic protein BCL2 [10].
|
|
|
|



 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|
|